Symptom | Placebo | Fedotozine | Treatment effect (95% CI) | p Value |
Overall intensity | ||||
Inclusion | 1.48 (0.68) | 1.58 (0.68) | 0.09–0.16 | 0.261 |
Six weekly mean | 1.24 (0.78) | 1.14 (0.71) | −0.18–0.11 | 0.002 |
Epigastric pain | ||||
Inclusion | 1.20 (0.83) | 1.25 (0.84) | 0.05–0.20 | 0.638 |
Six weekly mean | 1.00 (0.86) | 0.87 (0.81) | −0.18–0.12 | 0.004 |
Inability to finish meal | ||||
Inclusion | 0.71 (0.80) | 0.84 (0.80) | 0.13–0.19 | 0.171 |
Six weekly mean | 0.59 (0.73) | 0.66 (0.76) | −0.03–0.10 | 0.592 |
Nausea | ||||
Inclusion | 0.62 (0.81) | 0.73 (0.76) | 0.11–0.19 | 0.238 |
Six weekly mean | 0.56 (0.74) | 0.52 (0.71) | −0.13–0.10 | 0.010 |
Slow digestion | ||||
Inclusion | 1.20 (0.80) | 1.17 (0.86) | 0.02–0.20 | 0.836 |
Six weekly mean | 0.96 (0.77) | 0.86 (0.74) | −0.08–0.12 | 0.157 |
Sensation of fullness | ||||
Inclusion | 1.38 (0.83) | 1.42 (0.75) | 0.04–0.19 | 0.643 |
Six weekly mean | 1.07 (0.84) | 0.98 (0.75) | −0.12–0.12 | 0.052 |
Global score | ||||
Inclusion | 1.02 (0.62) | 1.08 (0.62) | 0.06–0.15 | 0.433 |
Six weekly mean | 0.84 (0.63) | 0.78 (0.62) | −0.10–0.09 | 0.021 |
Results are expressed as mean (SD). CI, confidence interval.